Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma

NCT03933735

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California San Francisco (UCSF) - Parnassus Heights /ID# 238680 San Francisco, California, United States
  • Tulane University School of Medicine /ID# 242322 New Orleans, Louisiana, United States
  • Mayo Clinic - Rochester /ID# 238683 Rochester, Minnesota, United States
  • Washington University-School of Medicine /ID# 238681 St Louis, Missouri, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

NCT06097364

Conditions
Disease Attributes, Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, +12 more
Locations
  • Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
  • Investigative Clinical Research of Indiana Noblesville, Indiana, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
  • University of Kentucky Lexington, Kentucky, United States
View all 145 locations
View Trial Details
Active, Not Recruiting

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

NCT04938232

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
Locations
  • University of Chicago Medicine Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia

NCT04624906

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details

Related conditions